Spatial Aptamer Co-Assays for mRNA-Protein Signal Co-Localization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing spatial assays struggle to co-localize mRNA and protein signals effectively, as commercially available methods are limited in detecting proteins and face challenges such as protein binding interference, aptamer removal difficulty, and protein abundance dynamic range issues.

Innovation Solution

Aptamers are used to prepare spatial proteome sequencing libraries by associating with proteins, removing unbound aptamers, and releasing target nucleotide sequences for capture, with methods involving ultraviolet radiation, enzymes, or chemical cleavage to address these challenges.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If a long sequence is added to the aptamer to enable capture on the barcoded surface, then capture capability is improved, but protein binding by the aptamer is impacted

Engineering Contradiction:
Improvecapture capabilityVSAvoidprotein binding
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The aptamer is divided into two functional segments: a capture sequence (5'-terminal) that binds to the barcoded surface and a protein-binding sequence (3'-terminal) that interacts with the target protein. This segmentation allows each part to perform its specific function independently, resolving the conflict between capture capability and protein binding affinity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The aptamer acts as an intermediary molecule between the barcoded surface and the target protein. It simultaneously interacts with both the surface (via capture sequence) and the protein (via protein-binding sequence), enabling indirect capture without requiring the capture sequence to directly bind the protein.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Difficulty of detecting and measuring

If aptamers are used to detect proteins in situ, then detection capability is improved, but aptamers are difficult to remove from their target proteins

Engineering Contradiction:
Improvedetection capabilityVSAvoidaptamer removal
Core Design Contradiction:
Difficulty of detecting and measuringVSEase of operation

Solution Approach 1:

A cleavable linkage is pre-installed between the aptamer and the barcoded surface. After the aptamer binds to the protein, a cleavage agent is applied to break the linkage, releasing the aptamer-protein complex from the surface. This preliminary preparation of the cleavable linkage enables controlled release without requiring forceful removal methods.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The cleavable linkage is designed to be stable under normal assay conditions but can be broken by specific cleavage agents (chemical, enzymatic, or photolytic). By changing the chemical or physical parameters of the environment, the linkage can be selectively broken to release the aptamer from the surface.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If free aptamers are not prevented from binding to the barcoded surface, then capture efficiency is improved, but non-specific binding increases

Engineering Contradiction:
Improvecapture efficiencyVSAvoidspecificity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

Unbound aptamers are removed from the solution through washing steps before the capture process. This extraction of free aptamers prevents them from non-specifically binding to the barcoded surface, ensuring that only aptamers that have bound to their target proteins are captured.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The aptamer sequence is copied and amplified after capture to generate sufficient signal for detection. This copying process allows the system to work with low-abundance target proteins while maintaining specificity, as the amplification occurs after specific binding has already occurred.

Inventive Principle:
Principle #26Copying

4Measurement precision

If proteins are detected directly, then detection sensitivity is improved, but the large dynamic range of protein abundance makes quantification difficult

Engineering Contradiction:
Improvedetection sensitivityVSAvoidquantification complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The aptamer sequence is copied and amplified after capture to generate sufficient signal for detection. This copying process allows the system to work with low-abundance target proteins while maintaining specificity, as the amplification occurs after specific binding has already occurred.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The aptamer acts as an intermediary that bridges the gap between the target protein and the detection system. It binds to the protein with high affinity and then provides a detectable signal through its sequence, enabling sensitive detection across a wide dynamic range of protein abundances.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables efficient co-localization of mRNA and protein signals, overcoming protein binding interference and dynamic range issues, facilitating better understanding of gene expression and disease mechanisms.

Implementation Method 1

contacting a plurality of aptamers to the biological sample on the surface, the contacting resulting in association of individual aptamers in the plurality of aptamers with individual proteins in the biological sample

Methodology Applied
Scientific EffectSpecific binding:

Implementation Method 2

the plurality of aptamers is cleaved via ultraviolet radiation, an enzyme, or chemical cleavage

Methodology Applied
Scientific EffectUltraviolet radiation cleavage: Photodissociation

Implementation Method 3

the plurality of aptamers is cleaved via ultraviolet radiation, an enzyme, or chemical cleavage

Methodology Applied
Scientific EffectEnzymatic cleavage: Enzyme

Implementation Method 4

the plurality of aptamers is cleaved via ultraviolet radiation, an enzyme, or chemical cleavage

Methodology Applied
Scientific EffectChemical cleavage:

Implementation Method 5

each capture oligonucleotide in the plurality of capture oligonucleotides comprises (i) a capture nucleotide sequence at the 3′ end that is configured to bind to a target nucleotide sequence

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS20250361504A1Spatial mrna/protein co-assays using aptamers
Publication Date: 2025.11.27 ILLUMINA INC
  • US20250361504A1 patent drawing
  • US20250361504A1 patent drawing
  • US20250361504A1 patent drawing

AI summary

The present disclosure relates, in general, to methods of preparing a spatial proteome and/or transcriptome sequencing library. The spatial proteome and/or transcriptome sequencing library from a biological sample is useful, in some aspects, to determine a genetic profile and help diagnose a subject who has or is at risk of having a disorder, and improve treatment of the subject.